Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXDX | KYMR | RGEN | ||
| Company | Prometheus Biosciences Inc | Kymera Therapeutics Inc | Repligen Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 199.68 | 112.90 | 167.49 | ||
| High | 199.98 | 118.04 | 168.01 | ||
| Low | 199.60 | 110.05 | 165.05 | ||
| Last | 199.92 | 117.39 | 166.83 | ||
| Change | +0.18 | +2.97 | -0.66 | ||
| Percent Change | +0.09% | +2.60% | -0.39% | ||
| Volume | 1,860,600 | 468,500 | 598,100 | ||
| 20-Day Average Volume | 1,174,595 | 640,270 | 1,344,445 | ||
| Previous | 199.74 | 114.42 | 167.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 198.02 | 108.79 | 150.05 | ||
| 20-Day Raw Stochastic | 99.23% | 87.99% | 96.08% | ||
| 20-Day Relative Strength | 81.45 | 62.46 | 66.95 | ||
| Weighted Alpha | +110.70 | +139.36 | +39.45 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.47% since 06/08/23 | +9.18% since 08/07/26 | +1.79% since 08/07/26 | ||
| Low | 198.91 on 06/09/23 | 106.04 on 08/10/26 | 160.99 on 08/10/26 | ||
| High | 199.98 on 06/15/23 | 118.04 on 08/14/26 | 168.37 on 08/13/26 | ||
| 1-Month | |||||
| %Chg | +2.82% since 05/15/23 | +4.74% since 07/14/26 | +13.39% since 07/14/26 | ||
| Low | 189.76 on 05/16/23 | 99.52 on 08/03/26 | 129.00 on 07/21/26 | ||
| High | 199.98 on 06/15/23 | 119.83 on 07/20/26 | 168.37 on 08/13/26 | ||
| 3-Month | |||||
| %Chg | +72.97% since 03/15/23 | +38.92% since 05/14/26 | +61.38% since 05/14/26 | ||
| Low | 104.55 on 03/30/23 | 69.48 on 06/03/26 | 102.48 on 05/18/26 | ||
| High | 199.98 on 06/15/23 | 130.05 on 06/25/26 | 168.37 on 08/13/26 | ||
| 6-Month | |||||
| %Chg | +85.68% since 12/15/22 | +42.57% since 02/13/26 | +22.27% since 02/13/26 | ||
| Low | 103.33 on 01/06/23 | 69.48 on 06/03/26 | 100.99 on 05/14/26 | ||
| High | 199.98 on 06/15/23 | 130.05 on 06/25/26 | 168.37 on 08/13/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,558,772 | 9,761,096 | 9,415,218 | ||
| Shares Outstanding, K | 47,813 | 83,151 | 56,436 | ||
| Annual Sales, $M | 6,810,000 | 39,210,000 | 738,260,000 | ||
| Annual Net Income, $M | -141,750,000 | -311,350,000 | 48,890,000 | ||
| Last Qtr Sales, $M | 1,110,000 | 65,000,000 | 204,130,000 | ||
| Last Qtr Income, $M | -40,880,000 | -61,210,000 | 5,010,000 | ||
| 60-Month Beta | -0.49 | 1.95 | 1.03 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.86 on 05/09/23 | -0.62 on 08/05/26 | 0.54 on 07/28/26 | ||
| Latest Earnings Date | 08/10/23 | 11/03/26 | 10/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 85.02 | ||